# K072307: Quantitative Neuroq 3.0

- Pathway: 510(k) (Traditional)
- Applicant: Syntermed, Inc.
- Decided: Mar 14, 2008 after 210 days
- Product code: KPS (System, Tomography, Computed, Emission)
- Device class: 2
- Regulation: 21 CFR 892.1200
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K914350 (1991). 5 ancestors in all.
2 later devices descend from it; 2 cite it directly.
0 of 8 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K041022: Neuroq - Pet DP, Syntermed, Inc. (2004) Summary page 1.

## Most influential descendants
- K130451: Neuroq 3.6 (2013), 1 descendant of its own
- K180077: NeuroQ 3.8 (2018), 0 descendants of its own

## Indications for use
The NeuroQTM-PET DP program is indicated to perform a quantitative analysis of FDG-PET brain scans using a RO count method. NeuroQTM 3.0 provides added functionality which allows for analyzing the difference between two FDG-PET brain studies for the same patient, calculating values within user defined regions of interest, and displaying CT and PET brain studies for the patient.

Source page: https://510kreport.com/device/K072307
Methodology: https://510kreport.com/methodology